News

China Baicaotang posted a net income of $4.03m, or $0.13 per diluted share, compared to $3.07m, or $0.10 per diluted share, for the same period in 2008. Operating

Eribulin, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai. Eisai said that the submissions are based primarily on data from a

Aildenafil is close in structure to Sildenafil and is expected to possess a similar pharmacological and adverse event profile. Sildenafil is the active pharmaceutical ingredient in an FDA-approved

Alnylam said that in May 2008, the Japanese Patent Office had granted a related set of claims in the Tuschl II patent series (JP 4 095 895). The

Titan Pharma said that the Phase 3 study will be conducted at approximately 23 sites in the US and randomise approximately 250 patients into three arms: Probuphine (100

Antisense therapies target the proteins involved in disease processes through the RNA that is involved in building these proteins. The Isis discovery platform develops specific therapies that bind

Siemens claimed that Sitrans LVS100, which is used primarily for high or low level indication and redundancy of continuous level systems as overfill or dry run protection is

As per the terms of the agreement, AgaMatrix and sanofi-aventis are expected to co-develop solutions in diabetes management that incorporate AgaMatrix’s WaveSense technology. AgaMatrix’s proprietary WaveSense technology personalizes

Duodart is indicated in the treatment of moderate-to-severe symptoms of benign prostatic hyperplasia (BPH) and reduction in the risk of acute urinary retention (AUR) and surgery in patients